ACTRN12622000448741招募中未知
The FIrst Responder Shock Trial (FIRST): A cluster randomised controlled trial of the effect of smartphone-activated first responders with ultraportable defibrillators on 30-day survival in out-of-hospital cardiac arrest (OHCA)
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 714
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- o limit 至 o limit（—）
- 性别
- All
入选标准
- •All Out-of-hospital cardiac arrest confirmed by emergency medical services (EMS)
- •Activation of an eligible GoodSAM first responder where the responder accepts the alert and arrives on scene before EMS
排除标准
- •Patients with a Do Not Resuscitate (DNR) order or Advanced Care Directive
- •Cardiac arrests secondary to trauma or hanging
- •Locations where scene safety issues apply
研究者
相似试验
尚未招募
不适用
Effect of workplace mental health screening on help-seeking behaviour in first respondersHelp-seeking behaviour for psychological distress in first responders after workplace mental health screening.Mental health of first responders.Mental Health - DepressionMental Health - AnxietyMental Health - Other mental health disordersACTRN12621001457831niversity of New South Wales1,670
已完成
1 期
A Phase 1, Single-Center, Dose-Escalation and Fixed-Dose Crossover, Cohort Study to Determine the Safety and Pharmacokinetics of a Single Oral Dose of PF329 vs oral hydromorphone hydrochloride (HCl) in Healthy SubjectsACTRN12610000721000PharmacoFore, Inc.80
进行中（未招募）
1 期
A Phase I clinical trial to evaluate the safety and the activity of the oncolytic adenovirus VCN-01 in patients with refractory retinoblastomaEUCTR2016-001060-11-ESFundació Sant Joan de Déu
进行中（未招募）
1 期
Clinical trial to investigate the efficacy and safety of allo-APZ2-ACLF administered intravenously to patients suffering from acute-on-chronic liver failure.MedDRA version: 20.0Level: PTClassification code 10077305Term: Acute on chronic liver failureSystem Organ Class: 10019805 - Hepatobiliary disordersAcute-on-Chronic Liver FailureEUCTR2018-001240-61-DERHEACELL GmbH & Co. KG18
进行中（未招募）
1 期
Clinical trial to investigate the efficacy and safety of allo-APZ2-ACLF administered intravenously to patients suffering from acute-on-chronic liver failure.MedDRA version: 20.0Level: PTClassification code 10077305Term: Acute on chronic liver failureSystem Organ Class: 10019805 - Hepatobiliary disordersAcute-on-Chronic Liver FailureEUCTR2018-001240-61-ATRHEACELL GmbH & Co. KG40